NanoPharmaceuticals LLC
1 clinical trials · Sponsor
◉ Watch NanoPharmaceuticals LLC
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma (NCT05226494) | NanoPharmaceuticals LLC | 2022-06-23 |
Track NanoPharmaceuticals LLC automatically
Every clearance here is in the API, with alerts when new ones post.